Literature DB >> 25221626

Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Julia J Hsiao1, Edmond Teng2.   

Abstract

The updated diagnostic criteria for Alzheimer's disease (AD) distinguish three stages: dementia, symptomatic pre-dementia [i.e. mild cognitive impairment (MCI)], and asymptomatic pre-dementia. Although AD is primarily associated with cognitive deficits, co-morbid depressive symptoms frequently occur at each stage. Depression in AD dementia is qualitatively different from depression in cognitively intact and/or younger populations, and may be less responsive to established interventions. In MCI, depressive symptoms are associated with higher rates of progression to dementia, and may identify a subset of individuals that are more responsive to acetylcholinesterase inhibitor treatment. Clinical and subsyndromal depressive symptoms in cognitively normal elderly represent a risk factor and/or prodrome for dementia due to AD, but sustained antidepressant therapy may be able to modulate this risk.

Entities:  

Keywords:  Alzheimer's disease; assessment; dementia; depression; mild cognitive impairment; treatment

Year:  2013        PMID: 25221626      PMCID: PMC4160905          DOI: 10.2217/nmt.13.10

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  87 in total

1.  A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Authors:  H Feldman; S Gauthier; J Hecker; B Vellas; P Subbiah; E Whalen
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

3.  Cerebrospinal fluid biomarkers in Alzheimer's disease and geriatric depression: preliminary findings from Brazil.

Authors:  Taylor Reis; Carlos Otavio Brandão; Evandro Silva Freire Coutinho; Eliasz Engelhardt; Jerson Laks
Journal:  CNS Neurosci Ther       Date:  2012-04-25       Impact factor: 5.243

4.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors:  M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  The rate of conversion of mild cognitive impairment to dementia: predictive role of depression.

Authors:  T Gabryelewicz; M Styczynska; E Luczywek; A Barczak; A Pfeffer; W Androsiuk; M Chodakowska-Zebrowska; B Wasiak; B Peplonska; M Barcikowska
Journal:  Int J Geriatr Psychiatry       Date:  2007-06       Impact factor: 3.485

6.  The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Authors:  C Holmes; D Wilkinson; C Dean; S Vethanayagam; S Olivieri; A Langley; N D Pandita-Gunawardena; F Hogg; C Clare; J Damms
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

7.  Predictors of progression from mild cognitive impairment to Alzheimer disease.

Authors:  K Palmer; A K Berger; R Monastero; B Winblad; L Bäckman; L Fratiglioni
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

8.  Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment.

Authors:  L Rozzini; B Vicini Chilovi; M Conti; I Delrio; B Borroni; M Trabucchi; A Padovani
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-19       Impact factor: 2.959

9.  Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria.

Authors:  Edmond Teng; John M Ringman; Leslie K Ross; Ruth A Mulnard; Malcolm B Dick; George Bartzokis; Helen D Davies; Douglas Galasko; Linda Hewett; Dan Mungas; Bruce R Reed; Lon S Schneider; Freddi Segal-Gidan; Kristine Yaffe; Jeffrey L Cummings
Journal:  Am J Geriatr Psychiatry       Date:  2008-06       Impact factor: 4.105

10.  Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Authors:  P H Lu; S D Edland; E Teng; K Tingus; R C Petersen; J L Cummings
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

View more
  4 in total

1.  Late Life Depression: The Essentials and the Essential Distinctions.

Authors:  Sehba Husain-Krautter; James M Ellison
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-07-09

2.  Effects of Exercise Training on Anxious-Depressive-like Behavior in Alzheimer Rat.

Authors:  Chongyun Wu; Luodan Yang; Yong Li; Yan Dong; Baocheng Yang; Lorelei Donovan Tucker; Xuemei Zong; Quanguang Zhang
Journal:  Med Sci Sports Exerc       Date:  2020-07

Review 3.  Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities.

Authors:  Paul J Fitzgerald; Pho J Hale; Anjesh Ghimire; Brendon O Watson
Journal:  Front Behav Neurosci       Date:  2021-01-14       Impact factor: 3.558

Review 4.  Therapeutic non-invasive brain treatments in Alzheimer's disease: recent advances and challenges.

Authors:  Chongyun Wu; Luoman Yang; Shu Feng; Ling Zhu; Luodan Yang; Timon Cheng-Yi Liu; Rui Duan
Journal:  Inflamm Regen       Date:  2022-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.